US Stocks
/
Annovis Bio, Inc. Share Price
Annovis Bio, Inc. Share Price

Annovis Bio, Inc. Share Price

NYSE: ANVS | Micro Cap
$1.15
+$0.05 (4.55%) Last updated on 19 Sep, 2026 | 01:28 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Annovis Bio, Inc. Stock Performance

Open
$1.11
Prev. Close
$1.10
Circuit Range
N/A
Day Range
$1.10 - $1.16
Year Range
$1.07 - $5.50
Volume
32,874
Average Traded
$1.12

Annovis Bio, Inc. Share Price Today

As of 19 September 2026, Annovis Bio, Inc.'s share price is $1.15. The stock opened at $1.11, compared to its previous close of $1.10. During today's trading session, Annovis Bio, Inc.'s share price traded between $1.10 and $1.16, with an average price of $1.13. Over the past 52 weeks, the stock has recorded a high of $5.50 and a low of $1.07. In terms of performance, Annovis Bio, Inc.'s share price has declined by 48.20% over the last six months and is down 44.17% on a year-on-year basis.

Annovis Bio, Inc. Share Price Chart

$1.10$1.16
L
Show Current Price
H

Annovis Bio, Inc. Stock Fundamentals & Key Indicators

Market Cap
$23.63M
PE Ratio (TTM)
-0.82
Dividend Yield
N/A
EPS (TTM)
$-1.40
Revenue (TTM)
N/A
Return On Equity (TTM)
-171.23%
Profit Margin
N/A
Debt to Equity
0.22
Quarterly Earnings Growth YoY
42.53%

Annovis Bio, Inc. Quarterly Profit & Loss

All figures in USD

ParticularsMar 2024Jun 2024Sep 2024Mar 2025Jun 2025Sep 2025
RevenueN/AN/AN/AN/AN/AN/A
Net Profit-$1.07M-$5.02M-$12.64M-$5.54M-$6.22M-$7.26M
Net Profit MarginN/AN/AN/AN/AN/AN/A
Income ChangeN/A-370.54%-151.74%56.19%-12.33%-16.76%

Annovis Bio, Inc. Annual Profit & Loss

All figures in USD

Particulars20212022202320242025
RevenueN/AN/AN/AN/AN/A
Net Profit-$14.49M-$25.33M-$56.20M-$24.59M-$28.85M
Net Profit MarginN/AN/AN/AN/AN/A
Income ChangeN/A-74.83%-121.90%56.25%-17.34%

About Annovis Bio, Inc.

Annovis Bio, Inc., a clinical stage drug platform company, develops drugs to treat neurodegeneration in the United States. The company's lead product candidate is Buntanetap, which is in phase 2/3 to treat alzheimer's disease, as well as in phase 3 to treat parkinson's disease; and is in phase 2 clinical trial to treat lewy body dementia. It also develops ANVS405, which is in phase 2 and 3 clinical trials for the treatment of traumatic brain injury and/or stroke; and ANVS301, which finished phase 1 clinical trial to treat later stages of alzheimer's disease and dementia. The company was incorporated in 2008 and is headquartered in Malvern, Pennsylvania.

Annovis Bio, Inc. Historical Returns

MonthOpenCloseChange %
Sep 2026
$1.69
$1.15
-36.11%
Aug 2026
$1.75
$1.80
+2.86%
Jul 2026
$1.89
$1.75
-5.66%
Jun 2026
$1.96
$1.85
-3.39%
May 2026
$1.98
$1.92
-2.54%
Apr 2026
$2.26
$1.97
-11.26%
Mar 2026
$2.56
$2.22
-17.16%
Feb 2026
$2.70
$2.68
+0.00%
Jan 2026
$3.40
$2.68
-21.64%
Dec 2025
$5.09
$3.42
-32.94%
Nov 2025
$2.03
$5.10
+144.02%
Oct 2025
$2.06
$2.09
+1.46%

ANVS Share Price FAQs

What is Annovis Bio, Inc. share price today?

chevron-up
Annovis Bio, Inc. share price today is $1.15 as on September 19, 2026 at 1:28 am IST.

What is the 52 week high and 52 week low of Annovis Bio, Inc. stock?

chevron-up
The 52 week high of Annovis Bio, Inc. stock is $5.50, while the 52 week low is $1.07 as of 19 Sep '26.

What is ANVS's market capitalisation today?

chevron-up
ANVS market capitalisation is $23.63M as of September 19, 2026, at 1:38 pm IST.

What is ANVS's net income for the last quarter?

chevron-up
ANVS's net income for the last quarter is -0.01B USD.

What is the 5 year returns of ANVS?

chevron-up
The 5 year returns of ANVS is -96.37% as on 19 Sep '26.

What is the high & low stock price of ANVS today?

chevron-up
ANVS stock price hit a high of $1.16 and low of $1.10 as of 19 Sep '26.

Can I buy ANVS shares in India?

chevron-up
Yes. You can buy ANVS in India by opening an international trading account.